Pharmaceutical Executive
Record capital flows across global public and private markets has opened up new channels of investment in early-stage and novel science.
James Leech
Advertisement
Articles by James Leech
Advertisement
Latest Updated Articles
Cross-Border Funding in the Life SciencesAugust 21st 2018
Advertisement
Advertisement
Trending on PharmExec
1
AbbVie to Acquire Apogee Therapeutics in $10 Billion Deal
2
The Benefits and Challenges of 100 Percent US-Based Manufacturing
3
Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion
4
Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series A
5